Free Trial
NASDAQ:ONCO

Onconetix (ONCO) Stock Price, News & Analysis

Onconetix logo
$3.05 -0.08 (-2.56%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$3.01 -0.04 (-1.34%)
As of 09/12/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Onconetix Stock (NASDAQ:ONCO)

Key Stats

Today's Range
$3.03
$3.12
50-Day Range
$2.67
$4.91
52-Week Range
$2.61
$552.50
Volume
25,306 shs
Average Volume
45,814 shs
Market Capitalization
$4.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Onconetix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

ONCO MarketRank™: 

Onconetix scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Onconetix.

  • Price to Book Value per Share Ratio

    Onconetix has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.20% of the float of Onconetix has been sold short.
  • Short Interest Ratio / Days to Cover

    Onconetix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Onconetix has recently decreased by 6.62%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Onconetix does not currently pay a dividend.

  • Dividend Growth

    Onconetix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.20% of the float of Onconetix has been sold short.
  • Short Interest Ratio / Days to Cover

    Onconetix has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Onconetix has recently decreased by 6.62%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Onconetix has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Onconetix this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added Onconetix to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Onconetix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.10% of the stock of Onconetix is held by insiders.

  • Percentage Held by Institutions

    Only 23.89% of the stock of Onconetix is held by institutions.

  • Read more about Onconetix's insider trading history.
Receive ONCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Onconetix and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONCO Stock News Headlines

College grad makes $64,000 a month
A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.tc pixel
See More Headlines

ONCO Stock Analysis - Frequently Asked Questions

Onconetix's stock was trading at $53.55 at the start of the year. Since then, ONCO stock has decreased by 94.3% and is now trading at $3.05.

Onconetix, Inc. (NASDAQ:ONCO) announced its earnings results on Thursday, August, 14th. The company reported ($4.05) earnings per share for the quarter. The firm earned $0.11 million during the quarter. Onconetix had a negative trailing twelve-month return on equity of 192.74% and a negative net margin of 3,327.03%.

Shares of Onconetix reverse split on the morning of Friday, June 13th 2025.The 1-85 reverse split was announced on Wednesday, June 11th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of ONCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Onconetix investors own include QUALCOMM (QCOM), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID), Plug Power (PLUG) and Sirius XM (SIRI).

Company Calendar

Last Earnings
8/14/2025
Today
9/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONCO
Previous Symbol
NASDAQ:ONCO
CIK
1782107
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$58.69 million
Net Margins
-3,327.03%
Pretax Margin
-3,400.45%
Return on Equity
-192.74%
Return on Assets
-89.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$2.52 million
Price / Sales
1.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$11.22 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
1,550,000
Free Float
1,498,000
Market Cap
$4.73 million
Optionable
N/A
Beta
3.36
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ONCO) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners